“Glucagon-Like Peptide Receptor Agonists (GLP-1 Receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients With Type 2 Diabetes Mellitus”. Canadian Diabetes & Endocrinology Today 2, no. 3 (November 25, 2024): 31–35. Accessed August 24, 2026. https://CanadianDiabetesAndEndocrinologyToday.com/article/view/2-3-Girard.